Israel Carcinoembryonic Antigen Market (2025-2031) | Share, Competitive Landscape, Trends, Companies, Size & Revenue, Industry, Outlook, Segmentation, Analysis, Growth, Value, Forecast

Market Forecast By Application (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others) And Competitive Landscape
Product Code: ETC7647374 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sumit Sagar No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Israel Carcinoembryonic Antigen Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Israel`s import market for carcinoembryonic antigen in 2024 continued to be dominated by top exporting countries including Switzerland, USA, Germany, China, and Belgium. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a negative compound annual growth rate (CAGR) of -13.88% from 2020 to 2024. However, there was a positive growth rate of 8.63% from 2023 to 2024, suggesting potential shifts in market dynamics and opportunities for both Israeli importers and exporters in the year ahead.

Israel Carcinoembryonic Antigen Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • Israel Carcinoembryonic Antigen Market Outlook
  • Market Size of Israel Carcinoembryonic Antigen Market, 2024
  • Forecast of Israel Carcinoembryonic Antigen Market, 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Revenues & Volume for the Period 2021- 2031
  • Israel Carcinoembryonic Antigen Market Trend Evolution
  • Israel Carcinoembryonic Antigen Market Drivers and Challenges
  • Israel Carcinoembryonic Antigen Price Trends
  • Israel Carcinoembryonic Antigen Porter's Five Forces
  • Israel Carcinoembryonic Antigen Industry Life Cycle
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Pancreatic Cancer for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Ovarian Cancer for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Thyroid Cancer for the Period 2021- 2031
  • Historical Data and Forecast of Israel Carcinoembryonic Antigen Market Revenues & Volume By Others for the Period 2021- 2031
  • Israel Carcinoembryonic Antigen Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • Israel Carcinoembryonic Antigen Top Companies Market Share
  • Israel Carcinoembryonic Antigen Competitive Benchmarking By Technical and Operational Parameters
  • Israel Carcinoembryonic Antigen Company Profiles
  • Israel Carcinoembryonic Antigen Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Israel Carcinoembryonic Antigen Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Israel Carcinoembryonic Antigen Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Carcinoembryonic Antigen Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F

3.3 Israel Carcinoembryonic Antigen Market - Industry Life Cycle

3.4 Israel Carcinoembryonic Antigen Market - Porter's Five Forces

3.5 Israel Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F

4 Israel Carcinoembryonic Antigen Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Israel

4.2.2 Growing adoption of early cancer screening programs

4.2.3 Technological advancements in CEA testing

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for CEA tests

4.3.2 High cost associated with CEA testing

4.3.3 Limited reimbursement policies for CEA tests

5 Israel Carcinoembryonic Antigen Market Trends

6 Israel Carcinoembryonic Antigen Market, By Types

6.1 Israel Carcinoembryonic Antigen Market, By Application

6.1.1 Overview and Analysis

6.1.2 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.1.4 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F

6.1.6 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F

6.1.8 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F

7 Israel Carcinoembryonic Antigen Market Import-Export Trade Statistics

7.1 Israel Carcinoembryonic Antigen Market Export to Major Countries

7.2 Israel Carcinoembryonic Antigen Market Imports from Major Countries

8 Israel Carcinoembryonic Antigen Market Key Performance Indicators

8.1 Adoption rate of CEA testing in Israel

8.2 Number of new cancer cases detected through CEA testing

8.3 Investment in research and development for CEA testing technology

9 Israel Carcinoembryonic Antigen Market - Opportunity Assessment

9.1 Israel Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F

10 Israel Carcinoembryonic Antigen Market - Competitive Landscape

10.1 Israel Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024

10.2 Israel Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All